Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-10-2022 | Shock | Case report

AZD-1222/escitalopram/esomeprazole

Ventricular-tachycardia, soreness and mild pain at the site of injection: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Bassareo PP, et al. Ventricular tachycardia triggered by the first dose of an adenoviral vector-based COVID-19 vaccine in an adult patient with congenital heart disease. Clinical Case Reports 10: No. 9, Sep 2022. Available from: URL: http://doi.org/10.1002/ccr3.6064 Bassareo PP, et al. Ventricular tachycardia triggered by the first dose of an adenoviral vector-based COVID-19 vaccine in an adult patient with congenital heart disease. Clinical Case Reports 10: No. 9, Sep 2022. Available from: URL: http://​doi.​org/​10.​1002/​ccr3.​6064
Metadata
Title
AZD-1222/escitalopram/esomeprazole
Ventricular-tachycardia, soreness and mild pain at the site of injection: case report
Publication date
01-10-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26385-3

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Imatinib

Case report

Azathioprine